Table 2.
N | Mean CARES sexual interest a,b (n=461) | N | Mean CARES sexual dysfunction a,b (n=386) c | |||
---|---|---|---|---|---|---|
p-value | p-value | |||||
Treatment-associated amenorrhea | 0.002 | 0.002 | ||||
Amenorrhea | 210 | 1.41 | 172 | 1.58 | ||
No amenorrhea/Chemotherapy | 164 | 1.18 | 138 | 1.17 | ||
No amenorrhea/ No chemotherapy | 87 | 0.88 | 76 | 0.99 | ||
Tamoxifen | 0.07 | 0.52 | ||||
Yes | 272 | 1.07 | 231 | 1.21 | ||
No | 189 | 1.25 | 155 | 1.29 | ||
Radiation | 0.75 | 0.34 | ||||
Yes | 266 | 1.14 | 213 | 1.16 | ||
No | 195 | 1.18 | 173 | 1.33 | ||
Breast surgery | 0.34 | 0.08 | ||||
Lumpectomy | 142 | 1.10 | 113 | 1.31 | ||
Mastectomy | 60 | 1.10 | 48 | 0.99 | ||
Mastectomy + Reconstruction | 259 | 1.28 | 225 | 1.44 |
Abbreviations: CARES, Cancer Rehabilitation Evaluation System
Higher mean CARES scores are indicative of greater sexual interest problems (i.e., decreased interest) and sexual dysfunction
Adjusted for stage, age, race/ethnicity, partner status, time from diagnosis, and treatment variables included in table.
Sexual dysfunction analysis is restricted to women who reported being sexually active since diagnosis